- Home
- KLRS vs LGCY Comparison
KLRS vs LGCY Comparison
Compare KLRS & LGCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLRS
- LGCY
- Stock Information
- Founded
- KLRS 2019
- LGCY 2009
- Country
- KLRS United States
- LGCY United States
- Employees
- KLRS N/A
- LGCY N/A
- Industry
- KLRS Biotechnology: Biological Products (No Diagnostic Substances)
- LGCY
- Sector
- KLRS Health Care
- LGCY
- Exchange
- KLRS Nasdaq
- LGCY NYSE
- Market Cap
- KLRS 129.0M
- LGCY 117.7M
- IPO Year
- KLRS N/A
- LGCY 2024
- Fundamental
- Price
- KLRS $2.50
- LGCY $11.56
- Analyst Decision
- KLRS Buy
- LGCY Strong Buy
- Analyst Count
- KLRS 1
- LGCY 2
- Target Price
- KLRS N/A
- LGCY $10.65
- AVG Volume (30 Days)
- KLRS 38.9K
- LGCY 115.5K
- Earning Date
- KLRS 08-15-2025
- LGCY 05-15-2025
- Dividend Yield
- KLRS N/A
- LGCY N/A
- EPS Growth
- KLRS N/A
- LGCY 21.53
- EPS
- KLRS N/A
- LGCY 0.62
- Revenue
- KLRS N/A
- LGCY $58,970,210.00
- Revenue This Year
- KLRS N/A
- LGCY $33.77
- Revenue Next Year
- KLRS N/A
- LGCY $24.88
- P/E Ratio
- KLRS N/A
- LGCY $18.72
- Revenue Growth
- KLRS N/A
- LGCY 37.92
- 52 Week Low
- KLRS $2.28
- LGCY $3.60
- 52 Week High
- KLRS $24.15
- LGCY $12.14
- Technical
- Relative Strength Index (RSI)
- KLRS N/A
- LGCY N/A
- Support Level
- KLRS N/A
- LGCY N/A
- Resistance Level
- KLRS N/A
- LGCY N/A
- Average True Range (ATR)
- KLRS 0.00
- LGCY 0.00
- MACD
- KLRS 0.00
- LGCY 0.00
- Stochastic Oscillator
- KLRS 0.00
- LGCY 0.00
About KLRS Kalaris Therapeutics Inc. Common Stock
Kalaris Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing therapeutics. Kalaris is developing TH103, a novel, clinical stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body native, highest affinity VEGF receptor 1.
About LGCY LEGACY EDUCATION INC
Legacy Education Inc is engaged in career-focused, post-secondary education services to students at all stages of adult life, from recent high school graduates to working parents.